FA
AZN icon

Fiduciary Alliance’s AstraZeneca AZN Stock Holding History

Fiduciary Alliance’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-251
Closed -$35.9K – 229
2023
Q2 		$35.9K Buy
+251
New +$36.9K 0.01% 354
2023
Q1 		– Sell
-92
Closed -$12.5K – 203
2022
Q4 		$12.5K Buy
+92
New +$11.5K ﹤0.01% 376

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fiduciary Alliance's AZN Position: Q3 2023 in Review

Fiduciary Alliance sold out of AstraZeneca (AZN) in Q3 2023, closing a stake of 251 shares — an estimated $35.9K sold.

Fiduciary Alliance first reported a position in AZN in Q4 2022 and held it in 2 quarters. The position peaked at $35.9K in Q2 2023. 1,073 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

  • Fiduciary Alliance reported no remaining AstraZeneca position as of Q3 2023 after selling out during the quarter.
  • Fiduciary Alliance sold 251 AstraZeneca shares in Q3 2023, an estimated $35.9K.
  • Fiduciary Alliance first reported a position in AstraZeneca in Q4 2022 and held it in 2 quarters.
  • Fiduciary Alliance's AstraZeneca position peaked at $35.9K in Q2 2023.
  • 1,073 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on Fiduciary Alliance's 13F filing for Q3 2023, filed 18 Oct 2023.